dolichol-monophosphate and castanospermine

dolichol-monophosphate has been researched along with castanospermine* in 2 studies

Reviews

2 review(s) available for dolichol-monophosphate and castanospermine

ArticleYear
The importance of N-linked glycoproteins and dolichyl phosphate synthesis for fusion of L6 myoblasts.
    Biochemistry and cell biology = Biochimie et biologie cellulaire, 1992, Volume: 70, Issue:6

    Myoblasts fuse to form multinucleated myotubes, one of the early steps in the formation of multinucleated muscle fiber. The fusion reaction is accompanied by biochemical differentiation resulting in the expression of a variety of enzyme activities and macromolecules, particularly creatine phosphokinase. The fusing myoblast is thus an excellent system for use in studies on the molecular basis of cellular recognition. This report focuses on the role played by glycoproteins in this process. It was found that alteration of cell-surface glycoproteins, using oligosaccharide-processing inhibitors that interfered with the synthesis of the high-mannose type of N-linked oligosaccharide, resulted in the inhibition of both the fusion reaction and biochemical differentiation as determined by measurement of creatine phosphokinase. Ketoconazole, compactin, and lovastatin, which affect dolichol and cholesterol biosynthesis, were also potent fusion inhibitors. These observations, coupled with earlier studies on the characterization of fusion-defective myoblast cell lines defective in glycoprotein biosynthesis, point to the importance of surface glycoproteins in cellular recognition in L6 myoblasts.

    Topics: 1-Deoxynojirimycin; Animals; Carbohydrate Sequence; Cell Differentiation; Cell Fusion; Creatine Kinase; Dolichol Phosphates; Glycoproteins; Indolizines; Ketoconazole; Lovastatin; Molecular Sequence Data; Muscle Proteins; Muscles; Oligosaccharides; Rats; Stem Cells; Swainsonine

1992
Inhibitors of the biosynthesis and processing of N-linked oligosaccharides.
    CRC critical reviews in biochemistry, 1984, Volume: 16, Issue:1

    A number of glycoproteins have oligosaccharides linked to protein in a GlcNAc----asparagine bond. These oligosaccharides may be either of the complex, the high-mannose or the hybrid structure. Each type of oligosaccharides is initially biosynthesized via lipid-linked oligosaccharides to form a Glc3Man9GlcNAc2-pyrophosphoryl-dolichol and transfer of this oligosaccharide to protein. The oligosaccharide portion is then processed, first of all by removal of all three glucose residues to give a Man9GlcNAc2-protein. This structure may be the immediate precursor to the high-mannose structure or it may be further processed by the removal of a number of mannose residues. Initially four alpha 1,2-linked mannoses are removed to give a Man5 - GlcNAc2 -protein which is then lengthened by the addition of a GlcNAc residue. This new structure, the GlcNAc- Man5 - GlcNAc2 -protein, is the substrate for mannosidase II which removes the alpha 1,3- and alpha 1,6-linked mannoses . Then the other sugars, GlcNAc, galactose, and sialic acid, are added sequentially to give the complex types of glycoproteins. A number of inhibitors have been identified that interfere with glycoprotein biosynthesis, processing, or transport. Some of these inhibitors have been valuable tools to study the reaction pathways while others have been extremely useful for examining the role of carbohydrate in glycoprotein function. For example, tunicamycin and its analogs prevent protein glycosylation by inhibiting the first step in the lipid-linked pathway, i.e., the formation of Glc NAc-pyrophosphoryl-dolichol. These antibiotics have been widely used in a number of functional studies. Another antibiotic that inhibits the lipid-linked saccharide pathway is amphomycin, which blocks the formation of dolichyl-phosphoryl-mannose. In vitro, this antibiotic gives rise to a Man5GlcNAc2 -pyrophosphoryl-dolichol from GDP-[14C]mannose, indicating that the first five mannose residues come directly from GDP-mannose rather than from dolichyl-phosphoryl-mannose. Other antibodies that have been shown to act at the lipid-level are diumycin , tsushimycin , tridecaptin, and flavomycin. In addition to these types of compounds, a number of sugar analogs such as 2-deoxyglucose, fluoroglucose , glucosamine, etc. have been utilized in some interesting experiments. Several compounds have been shown to inhibit glycoprotein processing. One of these, the alkaloid swainsonine , inhibits mannosidase II that removes alpha-1,3 and alpha

    Topics: 1-Deoxynojirimycin; Acetylglucosamine; Alkaloids; Animals; Anti-Bacterial Agents; Asparagine; Bacitracin; Biological Transport; Carbohydrate Conformation; Cyclohexenes; Dolichol Phosphates; Glucosamine; Glucose; Glycoproteins; Hydroxycholesterols; Indolizines; Inositol; Lipopeptides; Lovastatin; Mannose; Naphthalenes; Oligopeptides; Oligosaccharides; Peptides; Peptides, Cyclic; Phospholipids; Polyisoprenyl Phosphate Monosaccharides; Pyrimidine Nucleosides; Showdomycin; Structure-Activity Relationship; Swainsonine; Tunicamycin; Uracil

1984